Latest News

What we're reading, May 27, 2016: treatment for pregnant women is often based on guesswork since few drugs are ever tested on them; a new superbug in the US is resistant to even the antibiotic of last resort; and how small physician practices can adapt to new payment models.
Dr Sophia Smith Discusses Attending to Patients' Psychosocial Needs
Having psychosocial support for patients with cancer, and for their family members, is critical, because patients often feel that their emotional needs are overlooked in busy clinics, said Sophia K. Smith, PhD, MSW, associate professor at the Duke School of Nursing.
Recent coverage of our peer-reviewed research, in the healthcare and mainstream press.
Bristol-Myers Squibb has challenged the recently released report by the Institute for Clinical and Economic Review that evaluates the clinical and cost effectiveness of newer treatments for multiple myeloma.
Dr Steve Miller Discusses Specialty Pharmacy's Role in New Care Delivery Models
High costs associated with specialty pharmacy will necessitate the evolution of a new specialized model to help ensure that patients are receiving the financial assistance they need and adhering to their treatment, according to Steve Miller, MD, senior vice president and chief medical officer of Express Scripts.
The collaboration is the latest in a series of partnerships for diabetes care announced by the medical device maker.
How would the proposed Patient Choice, Affordability, Responsibility, and Empowerment Act affect enrollment, premiums, federal spending, and out-of-pocket costs now that an estimated 20 million Americans have become newly insured?
Data sharing in precision medicine has not been without controversy. Some genetic testing companies say security on public databases is less than stellar, giving them a reason to decline sharing their information warehouses.
A new trial from the National Institutes of Health found that a lower systolic blood pressure goal of 120 mm Hg reduces risk of cardiovascular events in geriatric populations.
A new study published in the Journal of the National Cancer Institute has established that institutional volume can significantly influence survival in lung cancer patients receiving chemoradiation.
What we're reading, May 26, 2016: South Carolina passes a 20-week abortion ban, while Georgia's own law faces a new challenge; the FDA delays its decision on a controversial drug for Duchenne muscular dystrophy; and report highlights how Cover Oregon was mishandled.
Results from the phase 3 trials will be presented next month at the American Diabetes Association Scientific Sessions in New Orleans.
The practical document will be of greatest use to smaller hospitals still building antibiotic stewardship programs from scratch. CDC estimates that drug-resistant bacteria infect 2 million people a year and cause 23,000 deaths.
Dr Pamela Becker: Bar Is Set Very High to Meet Biosimilar Definition
The bar is set very high in terms of the biosimilar requirement definition, and physicians who are hesitant about substituting biosimilars for treatment should not be worried about the perceived differences, according to Pamela S. Becker, MD, PhD, professor of medicine in the Division of Hematology at the University of Washington School of Medicine.

From the Journals

The earliest studies involving diabetes therapy for Alzheimer’s are recruiting patients.
As primary care physicians and leaders of Wellframe—a mobile health company working with payers and physicians groups to extend care between visits for patients with complex comorbidities—Drs Panch and Goodman discuss their experiences building a mobile application used by elderly patients to communicate with clinicians and manage chronic disease.
When providers move from employing traditional practices to new methods that are steeped in evidence, this benefits patient health. The result is higher-quality, more affordable care, often stemming from lower rates of hospital infections, readmissions, and, in general, improved outcomes.
Authors from the University of Minnesota College of Pharmacy highlight the role that pharmacists can play in care optimization for seniors with chronic conditions.
Now that Medicare is poised to pay for the Diabetes Prevention Program, the next question is how to make it scalable.
How does the largest payer in a state with a large senior population respond to the rising need for diabetes care and prevention?
The authors discuss a simple strategy for payers to ensure more patients with type 2 diabetes achieve control of A1C.
A recent Diabetes Care study found flaws in Medicare's competitive bidding program for diabetes test strips. Two of that study's co-authors discuss the findings and why CMS should suspend the bidding program.
The author, who has lived with type 1 diabetes for more than 50 years, shares his account of a successful appeal of Medicare's policy of refusing to pay for continuous glucose monitoring (CGM.)
right-arrow
Featured Content
Compendia
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
HF Compendium
HF Compendium

Most Popular

Upcoming Partner Events
16-17 June, 2016
Philadelphia, US
August 17-18, 2016
Philadelphia, PA
August 23-24, 2016
Chicago, IL
October 19-20, 2016
Scottsdale, AZ

AJMC Strategic Alliance

$vacMongoViewPlus$